Redhill Biopharma
RDHL
#10900
Rank
โ‚ฌ3.58 M
Marketcap
0,59ย โ‚ฌ
Share price
-4.29%
Change (1 day)
-58.10%
Change (1 year)

Redhill Biopharma (RDHL) - Total assets

Total assets on the balance sheet as of December 2025 : โ‚ฌ22.27 Million

According to Redhill Biopharma's latest financial reports the company's total assets are โ‚ฌ22.27 Million. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

Redhill Biopharma - Total assets on balance sheet (from 2011 to 2025)

Total assets by year

Year Total assets Change
2025-12-31โ‚ฌ21.57 M24.43%
2024-12-31โ‚ฌ17.33 M-16.83%
2023-12-31โ‚ฌ20.84 M-85.92%
2022-12-31โ‚ฌ0.14 B-7.43%
2021-12-31โ‚ฌ0.15 B9.18%
2020-12-31โ‚ฌ0.14 B121.54%
2019-12-31โ‚ฌ66.14 M21.25%
2018-12-31โ‚ฌ54.55 M14.15%
2017-12-31โ‚ฌ47.79 M-32.26%
2016-12-31โ‚ฌ70.55 M15.44%
2015-12-31โ‚ฌ61.11 M157.6%
2014-12-31โ‚ฌ23.72 M128.49%
2013-12-31โ‚ฌ10.38 M-31.65%
2012-12-31โ‚ฌ15.19 M-2.26%
2011-12-31โ‚ฌ15.54 M

Total Assets for similar companies or competitors

Company Total assets differencediff. Country
Sanofi
SNY
โ‚ฌ130.24 B 584,543.91%๐Ÿ‡ซ๐Ÿ‡ท France
Merck
MRK
โ‚ฌ113.11 B 507,633.28%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
โ‚ฌ73.18 B 328,403.45%๐Ÿ‡ฌ๐Ÿ‡ง UK
Teva Pharmaceutical Industries
TEVA
โ‚ฌ35.19 B 157,879.88%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Taro Pharmaceutical
TARO
โ‚ฌ1.90 B 8,434.94%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel